AU2001289606A1 - Dry powder formulation comprising racecadotril - Google Patents

Dry powder formulation comprising racecadotril

Info

Publication number
AU2001289606A1
AU2001289606A1 AU2001289606A AU8960601A AU2001289606A1 AU 2001289606 A1 AU2001289606 A1 AU 2001289606A1 AU 2001289606 A AU2001289606 A AU 2001289606A AU 8960601 A AU8960601 A AU 8960601A AU 2001289606 A1 AU2001289606 A1 AU 2001289606A1
Authority
AU
Australia
Prior art keywords
dry powder
racecadotril
powder formulation
formulation
racedotril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289606A
Other languages
English (en)
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioprojet SC
Original Assignee
Bioprojet SC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet SC filed Critical Bioprojet SC
Publication of AU2001289606A1 publication Critical patent/AU2001289606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001289606A 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril Abandoned AU2001289606A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
EP00401799.2 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Publications (1)

Publication Number Publication Date
AU2001289606A1 true AU2001289606A1 (en) 2002-01-02

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289606A Abandoned AU2001289606A1 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Country Status (13)

Country Link
US (1) US6919093B2 (cs)
EP (1) EP1294372B1 (cs)
CN (2) CN1635884A (cs)
AT (1) ATE301999T1 (cs)
AU (1) AU2001289606A1 (cs)
BG (1) BG66212B1 (cs)
CA (1) CA2415957C (cs)
CZ (1) CZ299591B6 (cs)
DE (1) DE60112756T2 (cs)
DK (1) DK1294372T3 (cs)
ES (1) ES2247163T3 (cs)
SK (1) SK287819B6 (cs)
WO (1) WO2001097801A2 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (en) 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
US20140323512A1 (en) * 2011-10-18 2014-10-30 Purdue Pharma L.P. Acrylic Polymer Formulations
WO2014005032A1 (en) 2012-06-28 2014-01-03 Mcneil-Ppc, Inc. Racecadotril lipid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
CA2877724A1 (en) * 2012-06-28 2014-01-03 Der-Yang Lee Racecadotril liquid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
ES2549127T1 (es) 2014-03-10 2015-10-23 Galenicum Health S.L. Composiciones farmacéuticas que comprenden un principio activo
EP2949318A1 (en) * 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3558272A1 (en) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Oral pharmaceutical composition with improved taste-masking properties
WO2018163195A1 (en) 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (en) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Taste masked racecadotril tablet composition and process for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
EP0914822A4 (en) * 1996-03-14 2002-08-07 Bayer Ag PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
ATE301999T1 (de) 2005-09-15
WO2001097801A2 (en) 2001-12-27
CA2415957C (en) 2010-08-10
WO2001097801A3 (en) 2002-09-12
DE60112756D1 (de) 2005-09-22
CN1635884A (zh) 2005-07-06
CZ2003185A3 (cs) 2003-05-14
CN102151247A (zh) 2011-08-17
DK1294372T3 (da) 2005-09-19
US20030166718A1 (en) 2003-09-04
CA2415957A1 (en) 2001-12-27
BG66212B1 (bg) 2012-05-31
EP1294372A2 (en) 2003-03-26
US6919093B2 (en) 2005-07-19
DE60112756T2 (de) 2006-06-08
ES2247163T3 (es) 2006-03-01
SK762003A3 (en) 2003-07-01
SK287819B6 (sk) 2011-11-04
EP1294372B1 (en) 2005-08-17
CZ299591B6 (cs) 2008-09-10
BG107481A (bg) 2003-09-30

Similar Documents

Publication Publication Date Title
AU2001289606A1 (en) Dry powder formulation comprising racecadotril
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
EP1193270A3 (en) Pyrrolobenzodiazepines
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2002333644A1 (en) Dry powder medicament formulations
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
AU1164601A (en) Therapeutic use and formulation
AU2208401A (en) Inhibitors of complement activation, their preparation and use
AU2002354410A1 (en) Triazole compound and medicinal use thereof
EP1257255A4 (en) THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
AU2001260834A1 (en) The treatment of herpes
AU1167702A (en) Compositions comprising modafinil compounds
AUPQ866500A0 (en) Therapeutic compounds and methods
AU2001254961A1 (en) Agrochemical spray treatment and spray formulations
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001268236A1 (en) Use of aicar and related compounds
AU2811400A (en) Stable formulation containing fumagillin
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof